๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Interleukin-2 mediated restoration of natural killer cell function in a patient with Griscelli syndrome

โœ Scribed by Alessandro Plebani; Barbara Ciravegna; Marco Ponte; Maria C. Mingari; Lorenzo Moretta

Book ID
106122449
Publisher
Springer
Year
2000
Tongue
English
Weight
86 KB
Volume
159
Category
Article
ISSN
0340-6997

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Natural killer cells in children with ma
Natural killer cells in children with malignant solid tumors. Effect of recombinant interferon-ฮฑ and interleukin-2 on natural killer cell function against tumor cell lines
โœ Carlos S. Alvarado; Harry W. Findley; Wing C. Chan; Robert S. Hnath; Aly Abdel-M ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 708 KB

Natural killer (NK) cells and NK cell activity were determined in three groups (newly diagnosed [n = 211, on therapy [n = 211, and off therapy [n = 181) of children with various types of malignant solid tumors and in a control group (n = 26) by means of Leu-7 and Leu-llb monoclonal antibodies and a

Lack of correlation between peripheral b
Lack of correlation between peripheral blood lymphokine-activated killer (lak) cell function and clinical response in patients with advanced malignant melanoma receiving recombinant interleukin 2
โœ A. K. Ghosh; H. Dazzi; N. Thatcher; M. Moore ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 634 KB

A phase-1/11 study of recombinant interleukin 2 (rll-2) was performed in 31 melanoma patients. The first dose of rlL-2 was given intrasplenically followed 4 hr later by an i.v. dose and 3 further i.v. doses on alternate days. Three courses of treatment were planned at 3-week intervals. The maximum t